Table 3.
Beta-glucan assay results stratified by infection-inflammation status of the amniotic cavity, intra-amniotic infection, and the presence of an intrauterine contraceptive device (IUD).
| Women with an IUD | Women without an IUD | Overall | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Beta-glucan assay | Beta-glucan assay | Beta-glucan assay | ||||||
| Positive | Negative | Positive | Negative | Positive | Negative | |||
| Infection-inflammation status of the amniotic cavity | -Intra-amniotic infection with inflammation | 20 | 9 | 10 | 7 | 30 | 16 | 46 |
| -Intra-amniotic infection without inflammation | 1 | 0 | 3 | 5 | 4 | 5 | 9 | |
| -Absence of intra-amniotic infection and inflammation | 8 | 4 | 5 | 85 | 13 | 89 | 102 | |
| -Sterile inflammation | 13 | 3 | 3 | 21 | 16 | 24 | 40 | |
| Total | 42 | 16 | 21 | 118 | 63 | 134 | 197 | |
| Intra-amniotic infection | Candida spp. | 9 | 0 | 10 | 1 | 19 | 1 | 20 |
| -Candida species only | 8 | 0 | 7 | 0 | 15 | 0 | 15 | |
| -Candida spp. and non-fungal microorganism(s) | 1 | 0 | 3 | 1 | 4 | 1 | 5 | |
| Non-fungal microorganism(s) | 12 | 9 | 3 | 11 | 15 | 20 | 35 | |
| Absence of intra-amniotic infection | 21 | 7 | 8 | 106 | 29 | 113 | 142 | |
| Total | 42 | 16 | 21 | 118 | 63 | 134 | 197 | |